Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-02-27 @ 12:49 AM
Study NCT ID:
NCT04392505
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-29
First Post:
2020-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
Sponsor:
Oslo University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-08
First Submit QC Date:
None
Study First Post Date:
2020-05-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-28
Last Update Post Date:
2024-02-29
Last Update Post Date Type:
ACTUAL